Dysport Injections

Dysport® (abobotulinumtoxinA) represents a distinct formulation within the botulinum toxin type A family, engineered with properties that medical professionals value for specific treatment applications. Available in 300IU and 500IU vials, Dysport® is characterized by its broader diffusion pattern, making it particularly effective for treating larger surface areas where a more widespread, uniform effect is desired. This professional-grade neurotoxin has established itself as a trusted alternative with unique pharmacokinetics that appeal to experienced injectors seeking predictable, softening results.

Rapid-Action Formula for Comprehensive Treatment Zones

The scientific distinction of Dysport® lies in its molecular composition and smaller protein complex size, which contributes to its diffusion characteristics and rapid onset of action. Patients typically notice initial effects within 24-48 hours—among the fastest in its class—with full results manifesting within a week. This makes Dysport® an excellent choice for practitioners addressing the glabellar complex, forehead lines, and other regions where a smooth, blended aesthetic is the goal. The 300IU and 500IU presentations allow for efficient treatment of single or multiple areas with minimal vial waste, optimizing practice economics.

Key Professional Benefits & Treatment Advantages:

• Optimized for Larger Areas: The characteristic diffusion profile makes Dysport® particularly effective for forehead, platysmal bands, and other zones where a uniform, widespread effect is preferable to highly localized pinpoint relaxation.

• Rapid Patient Satisfaction: Noticeable effects often appear within 1-2 days, providing patients with quick visual feedback and high satisfaction rates.

• Dual Sizing for Practice Efficiency: The 300IU vial is ideal for focused treatment plans, while the 500IU option offers better value for high-volume practices, full-face treatments, or hyperhidrosis protocols, reducing per-unit cost.

• Proven Efficacy Profile: Backed by extensive clinical research and global regulatory approvals for aesthetic and therapeutic use, ensuring confidence in treatment outcomes.

• Consistent & Reliable: Manufactured under stringent quality controls to guarantee uniform potency and performance across every batch.

Clinical Specifications & Handling Protocol:

• Active Ingredient: AbobotulinumtoxinA (Botulinum Toxin Type A)

• Available Strengths: 300 International Units (IU) and 500 IU per vial

• Formulation: Lyophilized powder in a sterile, single-use glass vial

• Important Note on Units: Dysport® units are not interchangeable with other botulinum toxin products (e.g., Botox®). Dosing, conversion, and dilution are unique and must follow Dysport®-specific protocols and practitioner training.

• Reconstitution: Requires reconstitution with sterile 0.9% sodium chloride (without preservatives) according to the manufacturer’s guidelines and the practitioner’s established technique.

• Storage: Store unopened vials refrigerated at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light. Use immediately after reconstitution.

• Professional Use Only: This is a prescription-only medicinal product. Treatment requires a thorough patient medical assessment, understanding of facial anatomy, and appropriate injection technique. Contraindications include hypersensitivity to any component, infection at the injection site, and certain neurological disorders.